|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2005; 46:1643-1648, doi:10.1016/j.jacc.2005.01.067 © 2005 by the American College of Cardiology Foundation |
,¶
* Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
Laboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
|| Department of Cardiology, King’s College, London, United Kingdom
¶ Cardiology Division, Emory University, Atlanta, Georgia
# Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
** University of Chicago Hospitals, Chicago, Illinois
Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland
Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland
Manuscript received October 25, 2004; revised manuscript received January 24, 2005, accepted January 25, 2005.
* Reprint requests and correspondence: Dr. Richard O. Cannon III, National Institutes of Health, Building 10, Room 7B15, 10 Center Drive, MSC 1650, Bethesda, Maryland 20892-1650. (Email: Jonathan.Hill{at}kcl.ac.uk; cannonr{at}nih.gov).
* Dr. Jonathan M. Hill, King’s College London, Department of Cardiology, Bessemer Road, London SE5 9PJ, United Kingdom. (Email: Jonathan.Hill{at}kcl.ac.uk; cannonr{at}nih.gov).
OBJECTIVES: Cytokine mobilization of progenitor cells from bone marrow may promote myocardial neovascularization with relief of ischemia.
BACKGROUND: Patients with coronary artery disease (CAD) have low numbers of endothelial progenitor cells compared with healthy subjects.
METHODS: Granulocyte colony-stimulating factor (G-CSF), 10 µg/kg/day for five days, was administered to 16 CAD patients. Progenitor cells were measured by flow cytometry; ischemia was assessed by exercise stress testing and by dobutamine stress cardiac magnetic resonance imaging.
RESULTS: Granulocyte colony-stimulating factor increased CD34+/CD133+ cells in the circulation from 1.5 ± 0.2 µl to 52.4 ± 10.4 µl (p < 0.001), similar to the response observed in 15 healthy subjects (75.1 ± 12.6 µl, p = 0.173). Indices of platelet and coagulation activation were not changed by treatment, but C-reactive protein increased from 4.5 ± 1.3 mg/l to 8.6 ± 1.3 mg/l (p = 0.017). Two patients experienced serious adverse events: 1) non–ST-segment elevation myocardial infarction (MI) 8 h after the fifth G-CSF dose, and 2) MI and death 17 days after treatment. At 1 month after treatment, there was no improvement from baseline values (i.e., reduction) in wall motion score (from 25.7 ± 2.1 to 28.3 ± 1.9, p = 0.196) or segments with abnormal perfusion (7.6 ± 1.1 to 7.7 ± 1.1, p = 0.916) and a trend towards a greater number of ischemic segments (from 4.5 ± 0.6 to 6.1 ± 1.0, p = 0.068). There was no improvement in exercise duration at 1 month (p = 0.37) or at 3 months (p = 0.98) versus baseline.
CONCLUSIONS: Granulocyte colony-stimulating factor administration to CAD patients mobilizes cells with endothelial progenitor potential from bone marrow, but without objective evidence of cardiac benefit and with the potential for adverse outcomes in some patients.
| |||||||||||||
Related articles in JACC:
This article has been cited by other articles:
|
|
 |
|
  H Ince, M Valgimigli, M Petzsch, J S. de Lezo, F Kuethe, S Dunkelmann, G Biondi-Zoccai, and C A Nienaber Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis Heart, May 1, 2008; 94(5): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zohlnhofer, A. Dibra, T. Koppara, A. de Waha, R. S. Ripa, J. Kastrup, M. Valgimigli, A. Schomig, and A. Kastrati Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction: A Meta-Analysis J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1429 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Anderlini and R. E. Champlin Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges Blood, February 15, 2008; 111(4): 1767 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tongers and D. W. Losordo Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2843 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Haghighat, D. Weiss, M. K. Whalin, D. P. Cowan, and W. R. Taylor Granulocyte Colony-Stimulating Factor and Granulocyte Macrophage Colony-Stimulating Factor Exacerbate Atherosclerosis in Apolipoprotein E-Deficient Mice Circulation, April 17, 2007; 115(15): 2049 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Roberts, Q. Xiao, G. Weir, Q. Xu, and M. Jahangiri Endothelial Progenitor Cells are Mobilized After Cardiac Surgery Ann. Thorac. Surg., February 1, 2007; 83(2): 598 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Berry, K. P. Balachandran, P. L. L'Allier, J. Lesperance, R. Bonan, and K. G. Oldroyd Importance of collateral circulation in coronary heart disease Eur. Heart J., February 1, 2007; 28(3): 278 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kastrup, R. S. Ripa, Y. Wang, and E. Jorgensen Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Eur. Heart J., December 1, 2006; 27(23): 2748 - 2754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Saha, R Zbinden, S R Redwood, and M S Marber Stem cells to repair the broken heart: much ado about nothing? Heart, December 1, 2006; 92(12): 1717 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Engelmann, H. D. Theiss, C. Hennig-Theiss, A. Huber, B. J. Wintersperger, A.-E. Werle-Ruedinger, S. O. Schoenberg, G. Steinbeck, and W.-M. Franz Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization: Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) Trial J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1712 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ben-Dor, S. Fuchs, and R. Kornowski Potential Hazards and Technical Considerations Associated With Myocardial Cell Transplantation Protocols for Ischemic Myocardial Syndrome J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1519 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Ripa, Y. Wang, E. Jorgensen, H. E. Johnsen, B. Hesse, and J. Kastrup Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease Eur. Heart J., August 1, 2006; 27(15): 1785 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Forrester, M. S. Lee, N. Kapoor, and R. R. Makkar The Janus Face of Drug-Eluting Stents J. Am. Coll. Cardiol., July 18, 2006; 48(2): 375 - 376. [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Cho, T.-Y. Kim, H.-J. Cho, K.-W. Park, S.-Y. Zhang, J.-H. Kim, S.-H. Kim, J.-Y. Hahn, H.-J. Kang, Y.-B. Park, et al. The Effect of Stem Cell Mobilization by Granulocyte-Colony Stimulating Factor on Neointimal Hyperplasia and Endothelial Healing After Vascular Injury With Bare-Metal Versus Paclitaxel-Eluting Stents J. Am. Coll. Cardiol., July 18, 2006; 48(2): 366 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Kang, H.-Y. Lee, S.-H. Na, S.-A Chang, K.-W. Park, H.-K. Kim, S.-Y. Kim, H.-J. Chang, W. Lee, W. J. Kang, et al. Differential Effect of Intracoronary Infusion of Mobilized Peripheral Blood Stem Cells by Granulocyte Colony-Stimulating Factor on Left Ventricular Function and Remodeling in Patients With Acute Myocardial Infarction Versus Old Myocardial Infarction: The MAGIC Cell-3-DES Randomized, Controlled Trial Circulation, July 4, 2006; 114(1_suppl): I-145 - I-151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Urao, M. Okigaki, H. Yamada, Y. Aadachi, K. Matsuno, A. Matsui, S. Matsunaga, K. Tateishi, T. Nomura, T. Takahashi, et al. Erythropoietin-Mobilized Endothelial Progenitors Enhance Reendothelialization via Akt-Endothelial Nitric Oxide Synthase Activation and Prevent Neointimal Hyperplasia Circ. Res., June 9, 2006; 98(11): 1405 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Deindl, M.-M. Zaruba, S. Brunner, B. Huber, U. Mehl, G. Assmann, I. E. Hoefer, J. Mueller-Hoecker, and W.-M. Franz G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis FASEB J, May 1, 2006; 20(7): 956 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Cho and Y.-s. Yoon Synergism of Hematopoietic Cytokines for Infarct Repair Circ. Res., April 28, 2006; 98(8): 990 - 992. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hill and J. Bartunek The End of Granulocyte Colony-Stimulating Factor in Acute Myocardial Infarction?: Reaping the Benefits Beyond Cytokine Mobilization Circulation, April 25, 2006; 113(16): 1926 - 1928. [Full Text] [PDF]
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1689 - 1706. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takamiya, M. Okigaki, D. Jin, S. Takai, Y. Nozawa, Y. Adachi, N. Urao, K. Tateishi, T. Nomura, K. Zen, et al. Granulocyte Colony-Stimulating Factor-Mobilized Circulating c-Kit+/Flk-1+ Progenitor Cells Regenerate Endothelium and Inhibit Neointimal Hyperplasia After Vascular Injury Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 751 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sainz and M. Sata Targeting bone marrow to treat vascular diseases: Accelerated vascular healing by colony stimulating factor Cardiovasc Res, April 1, 2006; 70(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zohlnhofer, I. Ott, J. Mehilli, K. Schomig, F. Michalk, T. Ibrahim, G. Meisetschlager, J. von Wedel, H. Bollwein, M. Seyfarth, et al. Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial JAMA, March 1, 2006; 295(9): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Wilson and T. D. Henry Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor: Double-Edged Swords J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1649 - 1650. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
